Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

11.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
11.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

5.3K
The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.3K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

7.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.2K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

10.4K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

9.7K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
9.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Changes in body composition and safety of exercise for individuals with severe cerebral palsy: single-group pre-post observational study.

Journal of physical therapy science·2026
Same author

Nogo-A-cleaved amino-terminal fragment but not Nogo-B regulates STAT3 activation.

Biochemical and biophysical research communications·2025
Same author

Early-Onset Wheeze Trajectories in Infants: The Phenotyping of Wheezing Infants (P-WIN) Study.

Pediatric pulmonology·2025
Same author

Diagnostic potential of allergen-specific lymphocyte stimulation test in hen's egg yolk-induced, food protein-induced enterocolitis syndrome.

The journal of allergy and clinical immunology. Global·2025
Same author

A selective RPL15 PROTAC degrader enhances anti-PD-1 immunotherapy in a murine melanoma tumor model.

Oncogene·2025
Same author

Ozonated olive oil inhibits melanoma proliferation by inducing ferroptosis.

Biochemistry and biophysics reports·2025

Related Experiment Video

Updated: Jan 9, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

604

[IL-6/STAT3 Signaling Pathways: Molecular Insights and Emerging Thereapeutic Targets].

Tadashi Matsuda1

  • 1Graduate School of Pharmaceutical Sciences, Hokkaido University.

Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan
|November 30, 2025
PubMed
Summary

Interleukin 6 (IL-6) signaling, particularly through STAT3, impacts cell growth and disease. Targeting IL-6 interacting proteins like TYK2 and STAP-2 offers new therapeutic strategies for cancer and autoimmune conditions.

Keywords:
cancerimmune diseaseinterleukin 6 (IL-6)signal transduction

More Related Videos

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
03:08

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Published on: October 3, 2025

879
Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
07:23

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome

Published on: June 15, 2016

8.9K

Related Experiment Videos

Last Updated: Jan 9, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

604
Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
03:08

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Published on: October 3, 2025

879
Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
07:23

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome

Published on: June 15, 2016

8.9K

Area of Science:

  • Molecular Biology
  • Immunology
  • Oncology

Background:

  • Interleukin 6 (IL-6) is a pleiotropic cytokine regulating diverse cellular processes including proliferation, differentiation, inflammation, immune responses, and homeostasis.
  • IL-6 signaling is implicated in tumorigenesis, notably myeloma cell growth, and its dysregulation is linked to cancer and autoimmune diseases.
  • The Janus Kinase (JAK)-Signal Transducer and Activator of Transcription (STAT) pathway, especially STAT3, is a critical mediator of IL-6 signals in both normal and pathological contexts.

Purpose of the Study:

  • To review the biological and molecular mechanisms of IL-6-mediated signals.
  • To identify STAT3-interacting proteins that modulate STAT3 signaling and crosstalk with other pathways.
  • To explore the therapeutic potential of targeting specific STAT3-interacting proteins, namely TYK2 and STAP-2.

Main Methods:

  • Literature review focusing on IL-6 signaling pathways.
  • Analysis of STAT3-interacting proteins and their roles in signal transduction.
  • Evaluation of tyrosine kinase 2 (TYK2) and signal-transducing adapter protein-2 (STAP-2) as potential therapeutic targets.

Main Results:

  • STAT3 plays a pivotal role in mediating IL-6 signals, with its dysregulation contributing to disease.
  • Identification of STAT3-interacting proteins that fine-tune STAT3-mediated signaling.
  • Tyrosine kinase 2 (TYK2) and signal-transducing adapter protein-2 (STAP-2) emerge as key regulators and potential therapeutic targets.

Conclusions:

  • Understanding IL-6/STAT3 pathway intricacies and interacting proteins is crucial for disease management.
  • Targeting TYK2 and STAP-2 presents a promising avenue for developing novel therapeutic strategies against IL-6-driven diseases.
  • Further research into these interactions could lead to innovative treatments for cancer and autoimmune disorders.